Browsing by Author Grande, Carlos
Showing results 1 to 6 of 6
| Issue Date | Title | Author(s) |
|---|---|---|
| Mar-2014 | Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial | Briones, Javier; Novelli, Silvana; García-Marco, José A.; Tomás, José F.; Bernal, Teresa; Grande, Carlos; Canales, Miguel A.; Torres, Antonio; Moraleda, José María; Panizo, Carlos Manuel; Jarque, Isidro; Palmero, Francisca; Hernández, Miguel; González Barca, Eva; López, Dulce; Caballero, Dolores; GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) |
| 12-Jul-2022 | Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups | Bastos Oreiro, Mariana; Gutiérrez, Antonio; Reguera, Juan Luís; Iacoboni, Gloria; López Corral, Lucía; Terol, María José; Ortíz Maldonado, Valentín; Sanz, Jaime; Guerra Dominguez, Luisa; Bailen, Rebeca; Mussetti, Alberto; Abrisqueta Costa, Pau; Hernani, Rafael; Luzardo, Hugo; Sancho, Juan Manuel; Delgado Serrano, Javier; Salar, Antonio; Grande, Carlos; Bento, Leyre; González de Villambrosía, Sonia; García Belmonte, Daniel; Sureda, Anna; Pérez Martínez, Antonio; Barba, Pere; Kwon, Mi; Martín García Sancho, Alejandro |
| 1-Oct-2016 | European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma | Zinzani, Pier Luigi; Karlin, Lionel; Radford, John; Caballero, Dolores; Fields, Paul; Chamuleau, Martine E. D.; D'Amore, Francesco; Haioun, Corinne; Thieblemont, Catherine; González Barca, Eva; Grande, Carlos; Johnson Peter W.; Imhoff, Gustaaf W. van; Ng, Thomas; Dwyer, Karen; Morschhauser, Franck |
| 1-Dec-2017 | Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma | Jiménez Ubieto, Ana; Grande, Carlos; Caballero, Dolores; Yáñez, Lucrecia; Novelli, Silvana; Hernández, Miguel T.; Manzanares, María; Arranz, Reyes; Ferreiro, José Javier; Bobillo, Sabela; Mercadal, Santiago; Galego, Andrea; López Jiménez, Javier; Moraleda, José María; Vallejo, Carlos; Albo, Carmen; Pérez, Elena; Marrero, Carmen; Magnano, Laura; Palomera, Luis; Jarque, Isidro; Coria, Erika; Rodriguez, Antonia; Martín, Alejandro; López Guillermo, Armando; Salar, Antonio; Lahuerta, Juan José; GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) |
| 1-Aug-2014 | Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis | Montes Moreno, Santiago; Batlle, Ana; González de Villambrosía, Sonia; Sánchez-Espiridión, Beatriz; Cereceda, Laura; González Barca, Eva; Purroy, Noelia; Pardal, Emilia; Martín, Alejandro; Grande, Carlos; Mazorra, Francisco; Insunza, Andrés; Quero, Cristina; Aguiar, David; Cruz, Miguel Ángel; Rueda Dominguez, Antonio; Llanos, Marta; Gómez Codina, Jose; García Arroyo, Francisco Ramón; Caballero, Dolores; Conde, Eulogio; López, Andres; Provencio, Mariano; Piris, Miguel A. |
| 25-Jan-2021 | R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group | Sancho, Juan Manuel; Fernández Alvarez, Rubén; Gual Capllonch, Francisco; González García, Esther; Grande, Carlos; Gutiérrez, Norma; Peñarrubia, María Jesús; Batlle López, Ana; González Barca, Eva; Guinea, José María; Gimeno, Eva; Peñalver, Francisco J.; Fuertes, Miguel; Bastos, Mariana; Hernández Rivas, José Ángel; Moraleda, José María; García, Olga; Sorigué, Marc; Martin, Alejandro |